Highlights
Ovarian vein thrombosis is rare, but a life-threatening condition.
It is rarer in non-pregnant women and in patients without history of recent pelvic surgery as the case in our patients.
The most commonly involved vein is the right ovarian vein, although in our case the left ovarian vein was affected.
Diagnosis of ovarian vein thrombosis can be by CT scan or MRI but the initial modality should be doppler ultrasound.
Highlights
Phlegmasia Cerulea Dolens, a rare & life-threatening condition caused by a massive DVT that is associated with arterial occlusion caused by the subsequent compartment syndrome.
Phlegmasia Cerulea Dolens could be a result of improper management of acute proximal DVT in the background of anatomical variabilities like May-Turner syndrome.
Despite the late presentation of such a rare condition there still a role for a limb preserving approach with endovascular techniques.
HighlightsPrimary carcinosarcoma is a rare neoplasm of the gallbladder.It is characterised by collision of adenocarcinomatous and sarcomatous components.This series shows that complete resection is the only means of extending survival.The role of adjuvant therapy remains unclear.
Highlights
Renal cell carcinoma (RCC) is an aggressive cancer accounting for 3% of all malignancies.
RCC has been reported to be one of the most common malignancies to cause solitary pancreatic metastasis.
Metastasis to thyroid is reported to occur in 1% of patients, and can present as late as 20 years after the resection of the primary tumor.
A high index of suspicion is crucial to detect RCC metastasis, in addition to life-long follow-up.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.